PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 153 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $20,823,000 | -39.8% | 916,927 | -37.5% | 1.66% | -49.9% |
Q2 2016 | $34,610,000 | +90.7% | 1,466,537 | +64.9% | 3.31% | +78.0% |
Q1 2016 | $18,148,000 | -63.2% | 889,607 | -7.2% | 1.86% | -49.7% |
Q4 2015 | $49,297,000 | +50.3% | 958,155 | +24.5% | 3.69% | +48.5% |
Q3 2015 | $32,802,000 | +371.6% | 769,641 | +404.0% | 2.48% | +336.0% |
Q2 2015 | $6,955,000 | -40.6% | 152,700 | -66.2% | 0.57% | -59.2% |
Q1 2014 | $11,712,000 | – | 452,194 | – | 1.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 232,952 | $5,498,000 | 5.39% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,673,727 | $86,700,000 | 3.41% |
Redmile Group, LLC | 1,466,537 | $34,610,000 | 3.31% |
SECTORAL ASSET MANAGEMENT INC | 1,229,382 | $29,013,000 | 3.00% |
HARVEY CAPITAL MANAGEMENT INC | 206,530 | $4,874,000 | 2.44% |
Marcus Capital, LLC | 75,150 | $1,774,000 | 1.87% |
Cormorant Asset Management, LP | 396,000 | $9,346,000 | 1.32% |
Rail-Splitter Capital Management, LLC | 221,414 | $5,225,000 | 1.25% |
Temasek Holdings (Private) Ltd | 6,583,568 | $155,372,000 | 1.21% |
EMERALD MUTUAL FUND ADVISERS TRUST | 636,526 | $15,022,000 | 0.84% |